Class II
Ongoing
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Why: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
- Company
- Leading Pharma, LLC
Fairfield, NJ, United States - Reported
- Apr 29, 2026
- Recall started
- Mar 20, 2026
- Where sold
- US Nationwide.
- Amount
- 9384 bottles
- Full product description
- Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
- Lots / codes affected
- Lots# H03125, H03225, H03325, Exp Date: 2027/08
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.